Business Context and Reporting Period
Filing identity: The supplied filing is Sonim Technologies, Inc.’s Form 10-K for the fiscal year ended December 31, 2022, filed March 20, 2023. It identifies the company as Sonim Technologies (Nasdaq: SONM), not “DNA X, Inc.” The filing reports annual results, not a standalone 2022 fourth quarter.
Sonim sells rugged mobile phones, accessories and, beginning in 2022, tablets. It sells mainly through wireless carriers and other channel partners. Tablets made up a substantial new product line, but revenue remained highly concentrated: the top four customers represented 83% of 2022 revenue, including one tablet customer responsible for 42%.
Key Financial Metrics
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Revenue | $69.8 million | $54.6 million |
| Gross profit / margin | $11.6 million / 16.6% | $6.4 million / 11.8% |
| Operating loss | $14.3 million | $38.0 million |
| Net loss | $14.1 million | $38.6 million |
| Adjusted EBITDA (non-GAAP) | $(9.9) million | $(34.7) million |
| Cash used in operating activities | $12.4 million | $38.5 million |
| Cash and cash equivalents at year-end | $13.2 million | $11.2 million |
At December 31, 2022, current assets were $43.6 million and current liabilities were $32.1 million. Accounts payable was $21.1 million. Debt was $147,000, classified as current; the filing reports no long-term debt at year-end. The balance sheet also included $6.8 million of capitalized contract fulfillment assets and $20.0 million of noncancelable purchase orders.
Material Changes Versus FY 2021
- Revenue increased 28%, principally with the addition of tablet sales; the audited product table reports $29.5 million of tablet revenue. Smartphone revenue rose to $17.8 million from $14.8 million, while feature-phone revenue fell to $21.3 million from $37.7 million.
- Gross margin rose to 16.6% from 11.8%, reflecting product mix and higher margins on the XP10, according to management.
- Operating expenses fell 42% to $25.9 million. Research and development declined to $8.0 million from $17.7 million, and legal expense to $1.1 million from $6.9 million.
- Net loss narrowed by $24.5 million. Operating cash use also declined, although 2022 cash flow included significant working-capital movements, including increases in accounts receivable and accounts payable.
- In July and August 2022, AJP Holding Company invested $17.5 million gross for shares; after approximately $3.1 million of transaction costs, the company reported $14.4 million of net proceeds. AJP held approximately 52% of the voting shares after the transaction. Shares outstanding increased materially.
Outlook, Risks and Unusual Items
- Going concern: The company and its auditor state that recurring losses raise substantial doubt about Sonim’s ability to continue as a going concern for at least one year from issuance of the financial statements. Management said it expected 2023 net loss to narrow significantly, with margins and operating expenses near the levels of the last two quarters of 2022, but also said future product development and financing are uncertain. No quantified revenue or earnings guidance is provided.
- Financing and liquidity: Management was evaluating potential equity, mezzanine or debt financing and other funding sources; availability on acceptable terms was not assured. The company expected to use cash and future product sales to meet obligations.
- Customer and receivables concentration: One tablet customer accounted for 42% of revenue and 84% of year-end receivables. The filing says payment terms for tablets are longer than traditional carrier sales and management considers the balance collectible. A reduction in orders or delayed collection could materially affect liquidity.
- Nasdaq listing: Sonim received a February 2023 minimum-bid-price deficiency notice and requested a hearing. It said its shares would remain listed pending the hearing process and contemplated a reverse stock split if needed; continued listing was not assured.
- Controls: Management concluded disclosure controls and internal control over financial reporting were ineffective at year-end because of a material weakness in IT general controls, including access controls over financial reporting systems. Management expected remediation in 2023; the weakness was not remediated during 2022.
- Operations and strategy: Sonim continued restructuring, outsourced manufacturing and software development, and pursued consumer-durable phones and additional data devices. Risks include reliance on third-party manufacturers and suppliers, carrier certification and purchase orders without minimum-volume commitments, and a small customer base.
- Unusual developments: The SEC notified Sonim on March 6, 2023 that it had concluded its investigation and did not intend to recommend enforcement action. Management expected lower legal expense in 2023. The AJP transaction also triggered approximately $1.2 million in severance costs for the former CFO and president.
- Reported-value discrepancy to check: MD&A attributes $25.5 million of 2022 revenue to tablet sales, while the audited revenue disaggregation reports $29.475 million. The filing also describes approximately 326,000 tablet units in one passage and 330,000 “tablets and other” units in its unit table.
Most Important Facts for Investors to Verify
- Confirm the filing’s registrant and ticker: the document is for Sonim Technologies, Inc. (SONM), despite the request metadata naming DNA X, Inc.
- Reconcile reported tablet revenue and unit figures, and assess whether tablet orders and collections continue as expected.
- Review the going-concern disclosures, cash runway, purchase commitments, and any subsequent financing or liquidity developments.
- Check the outcome of the Nasdaq hearing, any reverse split, and compliance with other listing standards.
- Track remediation and testing of the material weakness in financial reporting controls.
- Assess potential dilution from equity financing and outstanding awards; AJP’s 2022 investment gave it approximately 52% of voting shares.